| A patient-derived glioblastoma organoid model and biobank recapitulates inter-and intra-tumoral heterogeneity F Jacob, RD Salinas, DY Zhang, PTT Nguyen, JG Schnoll, SZH Wong, ... Cell 180 (1), 188-204. e22, 2020 | 844 | 2020 |
| The genetic landscape of the childhood cancer medulloblastoma DW Parsons, M Li, X Zhang, S Jones, RJ Leary, JCH Lin, SM Boca, ... science 331 (6016), 435-439, 2011 | 824 | 2011 |
| Long interspersed element-1 protein expression is a hallmark of many human cancers N Rodić, R Sharma, R Sharma, J Zampella, L Dai, MS Taylor, RH Hruban, ... The American journal of pathology 184 (5), 1280-1286, 2014 | 320 | 2014 |
| Checkpoint blockade reverses anergy in IL-13Rα2 humanized scFv-based CAR T cells to treat murine and canine gliomas Y Yin, AC Boesteanu, ZA Binder, C Xu, RA Reid, JL Rodriguez, DR Cook, ... Molecular Therapy-Oncolytics 11, 20-38, 2018 | 177 | 2018 |
| Radiomic MRI signature reveals three distinct subtypes of glioblastoma with different clinical and molecular characteristics, offering prognostic value beyond IDH1 S Rathore, H Akbari, M Rozycki, KG Abdullah, MLP Nasrallah, ZA Binder, ... Scientific reports 8 (1), 5087, 2018 | 176 | 2018 |
| Epidermal growth factor receptor extracellular domain mutations in glioblastoma present opportunities for clinical imaging and therapeutic development ZA Binder, AH Thorne, S Bakas, EP Wileyto, M Bilello, H Akbari, ... Cancer cell 34 (1), 163-177. e7, 2018 | 172 | 2018 |
| Abrogation of PIK3CA or PIK3R1 reduces proliferation, migration, and invasion in glioblastoma multiforme cells GL Weber, MO Parat, ZA Binder, GL Gallia, GJ Riggins Oncotarget 2 (11), 833, 2011 | 124 | 2011 |
| Wnt-mediated endothelial transformation into mesenchymal stem cell–like cells induces chemoresistance in glioblastoma M Huang, D Zhang, JY Wu, K Xing, E Yeo, C Li, L Zhang, E Holland, ... Science translational medicine 12 (532), eaay7522, 2020 | 119 | 2020 |
| Intrathecal bivalent CAR T cells targeting EGFR and IL13Rα2 in recurrent glioblastoma: phase 1 trial interim results SJ Bagley, M Logun, JA Fraietta, X Wang, AS Desai, LJ Bagley, ... Nature Medicine 30 (5), 1320-1329, 2024 | 110 | 2024 |
| Clinical utility of plasma cell-free DNA in adult patients with newly diagnosed glioblastoma: a pilot prospective study SJ Bagley, SA Nabavizadeh, JJ Mays, JE Till, JB Ware, S Levy, ... Clinical Cancer Research 26 (2), 397-407, 2020 | 108 | 2020 |
| The University of Pennsylvania glioblastoma (UPenn-GBM) cohort: advanced MRI, clinical, genomics, & radiomics S Bakas, C Sako, H Akbari, M Bilello, A Sotiras, G Shukla, JD Rudie, ... Scientific data 9 (1), 453, 2022 | 103 | 2022 |
| Targeting PAK4 to reprogram the vascular microenvironment and improve CAR-T immunotherapy for glioblastoma W Ma, Y Wang, R Zhang, F Yang, D Zhang, M Huang, L Zhang, JF Dorsey, ... Nature cancer 2 (1), 83-97, 2021 | 93 | 2021 |
| Exomic sequencing of four rare central nervous system tumor types C Bettegowda, N Agrawal, Y Jiao, Y Wang, LD Wood, FJ Rodriguez, ... Oncotarget 4 (4), 572, 2013 | 80 | 2013 |
| The role of STAT3 activation in modulating the immune microenvironment of GBM AP See, JE Han, J Phallen, Z Binder, G Gallia, F Pan, D Jinasena, ... Journal of neuro-oncology 110, 359-368, 2012 | 66 | 2012 |
| Case report: prolonged survival following EGFRvIII CAR T cell treatment for recurrent glioblastoma JS Durgin, F Henderson Jr, MLP Nasrallah, S Mohan, S Wang, SF Lacey, ... Frontiers in Oncology 11, 669071, 2021 | 61 | 2021 |
| EGFRvIII upregulates DNA mismatch repair resulting in increased temozolomide sensitivity of MGMT promoter methylated glioblastoma N Struve, ZA Binder, LF Stead, T Brend, SJ Bagley, C Faulkner, L Ott, ... Oncogene 39 (15), 3041-3055, 2020 | 59 | 2020 |
| Repeated peripheral infusions of anti-EGFRvIII CAR T cells in combination with pembrolizumab show no efficacy in glioblastoma: a phase 1 trial SJ Bagley, ZA Binder, L Lamrani, E Marinari, AS Desai, MLP Nasrallah, ... Nature Cancer 5 (3), 517-531, 2024 | 56 | 2024 |
| Locally secreted BiTEs complement CAR T cells by enhancing killing of antigen heterogeneous solid tumors Y Yin, JL Rodriguez, N Li, R Thokala, MLP Nasrallah, L Hu, L Zhang, ... Molecular Therapy 30 (7), 2537-2553, 2022 | 56 | 2022 |
| Podocalyxin-like protein is expressed in glioblastoma multiforme stem-like cells and is associated with poor outcome ZA Binder, IM Siu, CG Eberhart, C Ap Rhys, RY Bai, V Staedtke, H Zhang, ... PloS one 8 (10), e75945, 2013 | 53 | 2013 |
| Clinical activity of the EGFR tyrosine kinase inhibitor osimertinib in EGFR-mutant glioblastoma I Makhlin, RD Salinas, D Zhang, F Jacob, G Ming, H Song, D Saxena, ... CNS oncology 8 (3), CNS43, 2019 | 48 | 2019 |